Back to KLP KAPITALFORVALTNING AS KLP KAPITALFORVALTNING AS

COGTCOGT
7 quarters

Position history for KLP KAPITALFORVALTNING ASKLP KAPITALFORVALTNING AS's holdings in Cogent Biosciences, Inc.

KLP KAPITALFORVALTNING AS holds 27,800 shares of COGT (Cogent Biosciences, Inc.), worth $1.1M as of 2026-Q2. The position was increased (+50.3% shares). COGT represents 0.0% of KLP KAPITALFORVALTNING AS's portfolio.

Current Value

$1.1M

Current Shares

27,800

Total Value Change

+$987,720

Total Shares Change

+16,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
27,800
+50.3%
$1.1M0.0%$38.70
35
2026-Q1
Increased
18,500
+3.9%
$712,0650.0%$37.24
26
2025-Q4
Decreased
17,800
-5.8%
$632,2560.0%$37.12
0
2025-Q3
Unchanged
18,900
0.0%
$271,4040.0%$14.13
0
2025-Q2
Increased
18,900
+67.3%
$135,7020.0%$7.10
33
2025-Q1
Unchanged
11,300
0.0%
$67,6870.0%$6.48
0
2024-Q4
New
11,300
-
$88,1400.0%$7.71
30

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used